Inner ear schwannoma (IES), also known as intralabyrinthine schwannoma, is a rare benign tumor typically presenting with hearing loss, tinnitus, and vestibular symptoms. In some cases, vestibular manifestations mimic Ménière's disease, characterized by recurrent vertigo attacks in which endolymphatic hydrops has been implicated in the underlying pathophysiology....
✦ The floor
Discussion
Signed responses from readers of the wire.
Clinicians should be alert that inner ear schwannoma can mimic Ménière's disease; this single case suggests intratympanic gentamicin may palliate vertigo in such patients, but no change to standard practice is warranted based on one case report alone.
Inner ear schwannoma mimicking Ménière's disease is a rare but diagnostically important pitfall; documenting treatment responses helps build the sparse evidence base for managing this uncommon presentation.
- 01Inner ear schwannoma (a benign nerve tumor) presented with recurrent vertigo, hearing loss, and tinnitus mimicking Ménière's disease.
- 02Intratympanic gentamicin injection was used to ablate vestibular function and control vertigo symptoms.
- 03Published as a case report in Cureus (DOI: 10.7759/cureus.116464).
- 04Single-case evidence only; findings cannot be generalized to broader patient populations.
- 05Highlights the diagnostic challenge of distinguishing schwannoma from Ménière's disease on clinical grounds alone.
Intratympanic gentamicin controlled recurrent Ménière's disease-like vertigo caused by an inner ear schwannoma.
studypartially supportedInner ear schwannoma can present with symptoms indistinguishable from Ménière's disease, including vertigo, hearing loss, and tinnitus.
studysupported- PMID
- 42894823
- DOI
- 10.7759/cureus.116464.
- Journal
- Cureus
- Publication type
- case_report
- Evidence level
- 4
- Sample size
- 1
- Population
- Single patient with inner ear schwannoma presenting with recurrent Ménière's disease-like vertigo, hearing loss, and tinnitus
- Intervention
- Intratympanic gentamicin injection
Primary outcomes
Control of recurrent vertigo episodes; Symptom resolution (vertigo, hearing loss, tinnitus)